Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Is This Dividend Pharma Stock Going Against the Grain?
Motley Fool
Sat, 12/1/12 - 09:35 am
Merck
Will Merck's Odanacatib Sufficiently Fill Singulair's Void?
Motley Fool
Sat, 12/1/12 - 09:23 am
Merck
Odanacatib
osteoporosis
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
hepatitis C
Achillion
Gilead
Idenix
Merck
Medivir
Vertex Pharmaceuticals
FDA Rejection. EU Withdrawal. Set and Match?
Motley Fool
Fri, 11/30/12 - 09:39 am
FDA
Europe
ridaforolimus
Ariad Pharma
Merck
Merck in talks to buy Micro Labs
Financial Express, India
Thu, 11/29/12 - 10:43 am
Micro Labs
Merck
M&A
India
Merck withdraws Marketing Authorisation Application for ridaforolimus in Europe
The Fly on the Wall
Thu, 11/29/12 - 10:40 am
Europe
ridaforolimus
Merck
Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Yahoo/AP
Tue, 11/27/12 - 01:08 pm
Merck
Endocyte
Europe
vintafolide
ovarian cancer
Novo Nordisk says new data show Victoza advantage
Reuters
Tue, 11/27/12 - 10:36 am
diabetes
Novo Nordisk
Victoza
Merck
Amylin
J&J, Lilly, Merck plan clinical trial site database
Reuters
Thu, 11/15/12 - 11:13 am
JNJ
Eli Lilly
Merck
clinical trials
Merck - How To Play This 'Patent Cliff' With Options
Seeking Alpha
Thu, 11/15/12 - 10:49 am
patent cliff
Merck
Singulair
Odanacatib
Maxalt
MK-3475
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Teva
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novo Nordisk
Novartis
Pfizer
Sanofi
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thu, 11/15/12 - 10:45 am
diabetes
JNJ
Merck
Bristol-Myers Squibb
AstraZeneca
SGLT2 inhibitor
3 Potential Partners for Amarin
Motley Fool
Thu, 11/15/12 - 10:43 am
M&A
Amarin
AstraZeneca
Merck
Eli Lilly
Can You Profit From 4 Big Pharmas Making Headlines?
Motley Fool
Wed, 11/14/12 - 11:30 am
Abbott Labs
JNJ
Merck
Pfizer
'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production
Seeking Alpha
Wed, 11/14/12 - 11:13 am
Novavax
Flu
vaccines
GSK
Merck
Novartis
Sanofi
Bed Bugs Dying After Merck Drug Suggests Possible Weapon
Bloomberg
Tue, 11/13/12 - 12:10 pm
Merck
bed bugs
Stromectol
Merck ceases diabetes-cholesterol pill development
Marketwatch
Tue, 11/13/12 - 11:47 am
MK-0524B
MK-0431E
diabetes
Januvia
Merck
For NovaBay, Simplicity Is The Father Of Invention
Seeking Alpha
Mon, 11/12/12 - 11:29 am
NovaBay
Allergan
new molecular entity
NME
Forest Labs
Merck
Pfizer
Theravance
2 Risks Facing Merck Today
Motley Fool
Mon, 11/12/12 - 11:26 am
Merck
Vioxx
Azasite
Cancidas
Nasonex
Nexium
Noxafil
Vytorin
Zetia
Emend
generics
FDA reviewing Merck's experimental insomnia drug
Boston.com, MA
Fri, 11/9/12 - 10:03 am
FDA
Merck
suvorexant
insomnia
Pages
« first
‹ previous
…
134
135
136
137
138
139
140
141
142
…
next ›
last »